Relief Therapeutics Holding AG
Символ: 0QKQ.L
LSE
1.24
CHFПазарна цена днес
-0.1701
Съотношение P/E
-0.0019
Коефициент PEG
14.45M
MRK Cap
- 0.00%
Доходност на DIV
Relief Therapeutics Holding AG (0QKQ-L) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 76.46 | 19.2 | 44.8 | 43.2 | ||||||||
balance-sheet.row.short-term-investments | 0.01 | 0 | 0 | 0.2 | ||||||||
balance-sheet.row.net-receivables | 8.22 | 2.3 | 2.7 | 0.1 | ||||||||
balance-sheet.row.inventory | 1.48 | 0.2 | 0.4 | 0 | ||||||||
balance-sheet.row.other-current-assets | 6.08 | 0.9 | 7.1 | 3.6 | ||||||||
balance-sheet.row.total-current-assets | 92.23 | 22.6 | 55 | 46.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 11.31 | 2.7 | 2.5 | 0 | ||||||||
balance-sheet.row.goodwill | 15.58 | 7 | 8.7 | 0 | ||||||||
balance-sheet.row.intangible-assets | 450.83 | 162.9 | 192.3 | 30.8 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 466.42 | 169.9 | 201 | 30.8 | ||||||||
balance-sheet.row.long-term-investments | 38.83 | -7 | -8.7 | 0.4 | ||||||||
balance-sheet.row.tax-assets | 3.58 | 0.5 | 1.7 | 0 | ||||||||
balance-sheet.row.other-non-current-assets | 54.29 | 0.1 | 0.1 | 0 | ||||||||
balance-sheet.row.total-non-current-assets | 520.56 | 166.2 | 196.6 | 31.2 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 612.8 | 188.8 | 251.6 | 78 | ||||||||
balance-sheet.row.account-payables | 6.38 | 1.6 | 1.7 | 1.4 | ||||||||
balance-sheet.row.short-term-debt | 6.9 | 2.1 | 1.7 | 0.9 | ||||||||
balance-sheet.row.tax-payables | 0.35 | 0.3 | 0.5 | 0.4 | ||||||||
balance-sheet.row.long-term-debt-total | 0.42 | 0 | 0.4 | 0 | ||||||||
Deferred Revenue Non Current | 8.71 | 2.2 | 2.2 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 65.39 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 24.54 | 6.2 | 15.9 | 6.3 | ||||||||
balance-sheet.row.total-non-current-liabilities | 122.13 | 32.7 | 50.4 | 4.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 8.71 | 2.2 | 2.2 | 0 | ||||||||
balance-sheet.row.total-liab | 159.36 | 43.4 | 70.1 | 11 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 212.65 | 56.2 | 44.1 | 32.5 | ||||||||
balance-sheet.row.retained-earnings | -610.21 | -119.6 | -69.8 | -35.2 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 448.76 | 5.3 | 2.6 | 1.2 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 402.24 | 203.6 | 204.5 | 68.5 | ||||||||
balance-sheet.row.total-stockholders-equity | 453.44 | 145.4 | 181.5 | 67 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 612.8 | 188.8 | 251.6 | 78 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 453.44 | 145.4 | 181.5 | 67 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 612.8 | - | - | - | ||||||||
Total Investments | -14.03 | -7 | -8.7 | 0.4 | ||||||||
balance-sheet.row.total-debt | 16.03 | 4.3 | 4.3 | 0.9 | ||||||||
balance-sheet.row.net-debt | -60.43 | -14.9 | -40.5 | -42.3 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -148.97 | -50.8 | -34.7 | -7.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 7.18 | 3.9 | 2 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | -17.03 | -3.5 | -0.8 | 1.6 | ||||||||
cash-flows.row.stock-based-compensation | 2.7 | 2.2 | 1.1 | 1 | ||||||||
cash-flows.row.change-in-working-capital | 4.6 | 5.6 | -5.2 | 0 | ||||||||
cash-flows.row.account-receivables | 0.11 | 0 | -0.2 | 0 | ||||||||
cash-flows.row.inventory | -0.17 | 0.2 | -0.1 | 0 | ||||||||
cash-flows.row.account-payables | -0.67 | -0.1 | -0.8 | 1.2 | ||||||||
cash-flows.row.other-working-capital | -1.15 | 5.5 | -4.1 | -1.2 | ||||||||
cash-flows.row.other-non-cash-items | 127.68 | 18.6 | 1.9 | -13.1 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -41.63 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.97 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.acquisitions-net | -13.04 | -7.9 | -16.7 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 5.08 | 0 | 0 | 0 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0.46 | 0.5 | 0.1 | 3.3 | ||||||||
cash-flows.row.other-investing-activites | 9.05 | 0 | 0 | -0.2 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0.58 | -8 | -30.3 | 3 | ||||||||
cash-flows.row.debt-repayment | -0.18 | -0.1 | -5.6 | -0.5 | ||||||||
cash-flows.row.common-stock-issued | 12.21 | 7.1 | 76.1 | 58.3 | ||||||||
cash-flows.row.common-stock-repurchased | -0.72 | -0.2 | -2.8 | -0.6 | ||||||||
cash-flows.row.dividends-paid | 0 | -6.8 | -67.7 | -58.2 | ||||||||
cash-flows.row.other-financing-activites | 11.19 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 10.47 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.25 | 0.2 | -0.1 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | -30.2 | -25.5 | 1.6 | 43 | ||||||||
cash-flows.row.cash-at-end-of-period | 76.46 | 19.2 | 44.8 | 43.2 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 106.66 | 44.8 | 43.2 | 0.1 | ||||||||
cash-flows.row.operating-cash-flow | -41.63 | -24.1 | -35.7 | -18.2 | ||||||||
cash-flows.row.capital-expenditure | -0.97 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.free-cash-flow | -42.59 | -24.6 | -49.4 | -18.2 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 12.11 | 6.1 | 3.3 | 0 | ||||||||
income-statement-row.row.cost-of-revenue | 35 | 18.1 | 11.9 | 0 | ||||||||
income-statement-row.row.gross-profit | -22.89 | -12 | -8.6 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 13.72 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 11.32 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 4.75 | - | - | - | ||||||||
income-statement-row.row.other-expenses | -1.49 | -1.3 | -0.7 | -0.2 | ||||||||
income-statement-row.row.operating-expenses | 33.56 | 24.5 | 26.6 | 19.3 | ||||||||
income-statement-row.row.cost-and-expenses | 68.56 | 42.6 | 38.5 | 19.3 | ||||||||
income-statement-row.row.interest-income | 0.12 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0.27 | 0.2 | 0.3 | 0.2 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 4.75 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | -109.55 | -17.8 | -0.3 | 13 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | -1.49 | -1.3 | -0.7 | -0.2 | ||||||||
income-statement-row.row.total-operating-expenses | -109.55 | -17.8 | -0.3 | 13 | ||||||||
income-statement-row.row.interest-expense | 0.27 | 0.2 | 0.3 | 0.2 | ||||||||
income-statement-row.row.depreciation-and-amortization | 7.18 | 3.9 | 2 | 0 | ||||||||
income-statement-row.row.ebitda-caps | -49.27 | - | - | - | ||||||||
income-statement-row.row.operating-income | -56.45 | -36.5 | -35.2 | -19.3 | ||||||||
income-statement-row.row.income-before-tax | -166 | -54.3 | -35.5 | -6.3 | ||||||||
income-statement-row.row.income-tax-expense | -17.03 | -3.5 | -0.8 | 1.6 | ||||||||
income-statement-row.row.net-income | -148.97 | -50.8 | -34.7 | -7.8 |
Често задавани въпроси
Какво е Relief Therapeutics Holding AG (0QKQ.L) общи активи?
Relief Therapeutics Holding AG (0QKQ.L) общите активи са 188798000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 6033000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -1.861.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -1.861.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -13.782.
Какъв е общият приход на предприятието?
Общият приход е -4.644.
Каква е Relief Therapeutics Holding AG (0QKQ.L) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -50790000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 4344000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 24520000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 14556000.000.